Cargando…

Effectiveness of ocriplasmin in real‐world settings: A systematic literature review, meta‐analysis, and comparison with randomized trials

PURPOSE: Effectiveness of ocriplasmin for vitreomacular traction (VMT) varies depending on the presence of common ocular conditions and patient selection criteria. We carried out a systematic literature review and meta‐analysis of ocriplasmin studies conducted in real‐world settings (RWS) and compar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanani, Arshad M., Constantine, Ryan N., Blot, Koenraad H., Lescrauwaet, Benedicte, Szurman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518696/ https://www.ncbi.nlm.nih.gov/pubmed/33369248 http://dx.doi.org/10.1111/aos.14686

Ejemplares similares

Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature
por: Lescrauwaet, Benedicte, et al.
Publicado: (2019)

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016)

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)
por: Drenser, Kimberly A, et al.
Publicado: (2021)

Italian real-life experience on the use of ocriplasmin
por: Barca, Francesco, et al.
Publicado: (2018)

Ocriplasmin for Vitreoretinal Diseases
por: Tsui, Irena, et al.
Publicado: (2012)

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial
por: Blot, Koenraad, et al.
Publicado: (2019)

Ocriplasmin: who is the best candidate?
por: Prospero Ponce, Claudia M, et al.
Publicado: (2016)

Retinal breaks due to intravitreal ocriplasmin
por: Silva, Ruwan A, et al.
Publicado: (2014)

Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
por: Casswell, Edward, et al.
Publicado: (2014)

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

Myopic macular hole detachment associated with intravitreal ocriplasmin
por: Goh, Li Yen, et al.
Publicado: (2020)

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)

Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study
por: Mastropasqua, Rodolfo, et al.
Publicado: (2016)

Ocriplasmin use in a selected case with preserved visual acuity
por: Rossi, Settimio, et al.
Publicado: (2015)

Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
por: Song, Su Jeong, et al.
Publicado: (2014)

Release of experimental retinal vein occlusions by direct intraluminal injection of ocriplasmin
por: de Smet, Marc D, et al.
Publicado: (2016)

Assessment of Ocriplasmin Effects on the Vitreoretinal Compartment in Porcine and Human Model Systems
por: Jonckx, Bart, et al.
Publicado: (2017)

Floaters and reduced contrast sensitivity after successful pharmacologic vitreolysis with ocriplasmin
por: Khoshnevis, Matin, et al.
Publicado: (2016)

Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection
por: Chow, Nicholas, et al.
Publicado: (2018)

THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters
por: Sadda, SriniVas R., et al.
Publicado: (2019)

Mutational Analysis of Ocriplasmin to Reduce Proteolytic and Autolytic Activity in Pichia pastoris
por: Baghban, Roghayyeh, et al.
Publicado: (2020)

Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin
por: Baghban, Roghayyeh, et al.
Publicado: (2021)

Engineering of Ocriplasmin Variants by Bioinformatics Methods for the Reduction of Proteolytic and Autolytic Activities
por: Baghban, Roghayyeh, et al.
Publicado: (2021)

Efficacy and Safety of Ocriplasmin Use for Vitreomacular Adhesion and Its Predictive Factors: A Systematic Review and Meta-Analysis
por: Chen, Xi, et al.
Publicado: (2022)

Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment
por: Liang, I-Chia, et al.
Publicado: (2016)

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014)

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock, Michael, et al.
Publicado: (2015)

Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction
por: Rossi, Settimio, et al.
Publicado: (2016)

Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
por: Arrigo, Alessandro, et al.
Publicado: (2020)

Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
por: Katsanos, Andreas, et al.
Publicado: (2020)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
por: Furino, Claudio, et al.
Publicado: (2020)

Short-Term Results of Ocriplasmin versus Prompt Vitrectomy for Macular Hole. Which Performs Better?
por: Cacciamani, Andrea, et al.
Publicado: (2020)

EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy
por: Birch, David G., et al.
Publicado: (2018)

Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
por: Rosati, Alessandra, et al.
Publicado: (2018)

Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
por: Muqit, Mahiul M. K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hevafhvnk291os34pvi96k4af3